A Department of Defense–funded initiative targets underrepresented kidney cancer populations to improve clinical trial participation and address persistent disparities in access to novel therapies.

Susan Rux, RN, of Fox Chase Cancer Center, leads federally funded research to expand clinical trial access for underrepresented kidney cancer patients while mentoring the next generation of oncology ...

FDA authorized Tregzi for adults with acute leukemia, MDS, and other hematologic malignancies receiving closely matched donor ...

AURORA targets a high-unmet-need population: metastatic non-squamous NSCLC with progression on pembrolizumab and platinum ...

Learn why comprehensive biomarker testing is essential before starting any lung cancer treatment. Hear from patients and ...

Inclusive leadership is demonstrated through consistent respect, psychological safety, and communication that makes patients ...

Demonstrates mastery of cytokine-stimulating immunotherapy protocols, coordinating admissions, monitoring, and protocol-driven assessments with meticulous attention to detail and proactive ...

Oncology physical therapist Dr. Leslie Waltke demonstrates calf raises, a simple at-home exercise to help rebuild lower body ...

A UF Health oncologist answers the most common questions about cell therapy, from who qualifies to how it differs from ...

For Scerbo, the answer traces back to a single patient, a boy she met during her pediatric rotation who was being treated for ...

Navigating a cancer diagnosis often begins with a simple online search. The new Cancer Search Bar series from CURE brings those commonly searched questions directly to oncology ex ...